NVZMF:OTCMKTS
Novozymes A/S
63,99 $
0,00%
(0,00) 1 p
9. okt, 09:59:34 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NVZMF põhistatistika genereerimine…
Turu kapit.
180,58 mld
Keskm. maht
570,00
Maht
0,00
52 näd kõrgeim
72,98 $
52 näd madalaim
52,10 $
Beeta
0,82
Käibivad aktsiad
414,56 mln
Töötajate arv
11 tuh
Turu kapit.
180,58 mld
Keskm. maht
570,00
Maht
0,00
52 näd kõrgeim
72,98 $
52 näd madalaim
52,10 $
Beeta
0,82
Käibivad aktsiad
414,56 mln
Töötajate arv
11 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
StreetInsider
·
1 päeva eest
Transactions under Novonesis’ share buyback program
Simply Wall Street
·
1 päeva eest
Novozymes (CPSE:NSIS B) Expands Wisconsin Capacity, Is The Stock Still 12% Undervalued?
Profiil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Teave üksuse Novozymes A/S kohta
TegevjuhtEster Baiget
Töötajad11,1 tuh
Asutatud2000
Peakontorid-
SektorSpeciality chemicals
Veebisaitnovonesis.com